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Readers  are invited to use this article as a self-assessment 
exercise and to update  their knowledge. 
BACKGROUND 
Bacterial diarrheas cause the death of 1.5 million 
children under 5 years old each year. Escherichia coli 1s 
one of the most common diarrheagenic bacteria in 
both developing and developed countries. E. coli 
serotype 0 1  57:H7, not previously recognized as diarr- 
heagenic, was reported to be the causative agent of a 
multistate outbreak of hemorrhagic colitis (HC) in the 
USA in 1982. The illness was characterized by severe 
abdominal cramps, initially watery diarrhea followed 
by grossly bloody diarrhea and slight or no fever [l]. 
A number of outbreaks of E. coli 0157:H7 have been 
reported in other developed countries (Canada, Japan 
and Europe) since 1982, sometimes associated with 
hemolytic uremic syndrome (HUS). The recent out- 
break of E. coli 0157:H7 in Scotland (November- 
December 1996) involved about 400 cases. Ten patients 
died as a result of the infection, and a number of 
patients were seriously IU for several weeks [2 ] .  
DISCUSSION POINTS 
The increasing frequency of E. coli 0157:H7 outbreaks 
in developed countries and the gravity of such food 
poisoning mean that early identification of these patho- 
genic strains in patients from the first clinical symptoms 
of infection is vital. Diarrheagenic E. coli comprises 
a heterogeneous group of pathogenic bacteria. They 
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have been classified into six different pathotypes based 
on clinical aspects of the disease and identification 
of virulence factors produced by the isolates: entero- 
toxigenic E. coli (ETEC), enteroinvasive E. Cali (EIEC), 
enteroaggregative E. coli (EAEC), enteropathogenic 
E. coli (EPEC), diffusely adherent E. coli (DAEC) and 
Shiga-like toxin-producing E. coli (SLTEC). The fre- 
quency of each pathotype depends on the geographic 
area and varies among epidemiologic studies. 
MULTIPLE-CHOICE QUESTIONS 
In each o f t h e  numbered questions, a t  least one, and up tof ive ,  
.f the  individual entries are correct. ( n i e  answers are a t  the 
end .f this article.) 
1. With regard to enteric Escherichia coli 
(a) Enteropathogenic E. coli strains are 
the main cause of traveler’s diarrhea. True/False 
(b) All pathotypes produce toxins as 
virulence factors. True/False 
(c) The LT toxin of enterotoxigenic 
E. coli is similar to cholera toxin. True/ False 
(d) Only enteropathogenic E. coli strains 
cause ‘attaching and effacing lesions’. TrueiFalse 
(e) Enteroinvasive E. ~01i nfection 
typically presents as a dysentery-like 
illness. True/False 
2. With regard to SLTEC infection 
(a) Non-0157 strains are commonly 
implicated in cases in Europe. True/False 
(b) Direct person-to-person transmission 
does not occur. True/False 
(c)  The level of infectious inoculum 
is high. TrueiFalse 
(d) Cattle comprise the main reservoir 
of infection. TrueiFalse 
(e) Hemolytic uremic syndrome occurs 
in 25% of cases. True/False 
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3. With regard to HUS 
(a) It  is characterized by thrombasthenia. True/False 
(b) It is most frequently diagnosed in 
adults. True/False 
(c) It usually develops 1 week after the 
onset of harrhea. True/False 
(d) It may result in chronic renal impair- 
ment. True/False 
(e) It is only associated with SLTEC 
strains. True/False 
4. With regard to the Shiga-like toxins (SLT) 
(a) The type of SLT produced depends on 
the strain serotype. True/False 
(b) Almost all SLTEC strains produce 
SLT-11. True/False 
(c) All SLTs have a similar mechanism of 
action. True/False 
(d) SLT-I1 is the most potent. True/False 
(e) SLTs cause endothelial cell damage. True/False 
5. With regard to the identification of SLTEC 
strains 
(a) SLTEC strains are mostly detected in 
stools during the diarrheal phase of 
infection. True/False 
(b) SLTEC strains are often detected in 
the stools of patients with HUS. True/False 
(c) 0157  strains can be reliably detected 
using sorbitol-MacConkey plates. TrueIFalse 
(d) Serotyping of strains is only necessary 
during outbreaks. TrueIFalse 
(e) Antibodies against the lipopolysaccharide 
are often detected in patients. TrueIFalse 
6. With regard to the treatment of 
SLTEC infections 
(a) Resistance to commonly used antibiotics 
is a growing problem with SLTEC. True/False 
(b) - 10% of HUS patients require 
dialysis. TrueIFalse 
(c) HUS patients often require transhsions 
of erythrocytes and/or platelets. TrueIFalse 
(d) Antimotility agents increase the risk of 
progression to HUS. True/False 
(e) Long-term antibiotic therapy may be 
needed to effect clearance of the 
organism. True/False 
Question 1 
The mechanisms involved in altering intestinal electro- 
lyte transport depend on the E. coli pathotype. They 
may involve toxins, adherence to epithelial cells, in- 
vasion of epithelial cells or a combination of several 
factors [3]. 
ETEC strains are a major cause of diarrhea in 
children in developing countries and are the most 
important agents responsible for traveler’s diarrhea. 
They cause watery diarrhea and sometimes cholera-like 
syndromes with a risk of rapid dehydration, particularly 
in children. These E. coli strains produce two different 
types of toxins: LT (thermolabile toxin) and ST 
(thermostable toxin). Both toxins induce active fluid 
secretion. Detection of the toxins and toxin-encoding 
genes is used to identify an isolate as an ETEC strain. 
Production of these toxins requires prior colonization 
of the human intestinal epithelium which is mediated 
by colonization factor antigens or putative colonization 
factors; designation of these colonization factors varies 
depending on the investigators who have identified 
them. Adherence of ETEC strains to intestinal epith- 
elium does not seem to affect enterocytes or cause acute 
inflammation or tissue damage in vivo, but some strains 
invade intestinal cells in tissue-culture cells. The real 
significance of the invasive properties observed in vitro 
remains to be determined in vivo. The LT toxin has 
structural (75% identity at the amino acid level) and 
functional similarities to the cholera toxin. The toxin 
binds to the specific cell receptor GM1. It is then 
transferred to the cytosol of the epithelial cell, where it 
irreversibly ADP-ribosylates a stimulatory GTP-bind- 
ing protein. This activates the adenylate cyclase on the 
basolateral surface of the cell, causing an increase in the 
intracellular concentration of cyclic AMP. This may 
cause the selective opening of the chloride channels of 
the cell and the secretion of chloride and water into 
the intestinal lumen. The ST toxin binds to a specific 
receptor ST&, located on the apical surface of intestinal 
epithelial cells. It stimulates the guanylate cyclase 
activity of the STaR receptor. This causes an increase 
in intracellular cyclic GMP concentration which 
activates a cyclic AMP-dependent protein kinase. This 
causes chloride secretion and/or inhibits absorption of 
sodium and water. 
EIEC strains are responsible for dysenteric syn- 
dromes in developing countries. They cause a disease 
clinically indistinguishable from shigellosis. Abihty to 
invade intestinal epithelial cells is determined by the 
presence of a 140-MDa virulence plasmid similar to 
that of Shigellu strains. Detection of the invasion genes 
(mapping to a 35-kb region of the plasmid) is used to 
identify EIEC strains. The full process of epithelial cell 
invasion may involve four stages: (1) entry of bacteria 
into cells; (2)  multiplication of bacteria within epithelial 
cells; (3) intra- and intercellular spread of bacteria; and 
(4) killing of host cells. In addition, 75% ofEIEC strains 
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produce the Sen toxin, a molecule also synthesized by 
SIzigella strains. 
A heterogeneous group of E. coli strains associated 
with acute or persistent watery diarrhea have been 
identified that bind to human tissue-culture HEp-2 
or HeLa cells. Three subtypes of these enteroadherent 
E.  coli are identified according to their adherence 
pattern to HEp-2 cells. 
EAEC strains bind to epithelial cells in vivo and in 
vitro with an aggregative or ‘stacked-brick’ adherence 
pattern. This phenotype is associated with the presence 
of a 65-MDa virulence plasmid. This plasmid is also 
associated with cytotoxic effects such as exfoliation of 
mucosal epithelial cells in biopsy-derived intestinal 
niucosa from pediatric patients [4]. Detection of this 
plasmid allows identification of EAEC strains. A 120- 
kDa heat-labile enterotoxin secreted by EAEC strains 
has been identified that causes an increase in intra- 
cellular calcium concentration in HEp-2 cells and 
stimulates calcium-dependent protein phosphorylation. 
Some strains produce an ST-like toxin called EAST. 
Studies using human volunteers have demonstrated the 
pathogenicity of EAEC strains in human infections. 
EPEC strains cause a localized adherence pattern 
(LA). This phenotype is associated with the production 
of Bfp (bundle-forming pilus) fimbrial adhesins. The 
determinants coding for Bfp map to the EAF (EPEC 
adherence factor) plasmid. EPEC strains were identified 
as the causative agents of infantile gastroenteritis in 
developed countries in the 1950s. They are still a major 
cause of diarrhea in infants in developing countries. 
EPEC strains induce diarrhea if given orally to adult 
volunteers even if no toxin is detected. The charac- 
teristic intestinal epithelial cell lesions seen in vivo and 
in vitro, are known as ‘attaching and effacing lesions 
(A-E lesions)’. They are correlated with the presence 
of a chromosomal locus LEE (locus of enterocyte 
effacement) and with the intimin-encoding eaeA gene. 
The A-E phenotype results from an intimate adherence 
of bacteria associated with effacement of microvilli. 
Important rearrangements of the cytoskeleton are 
observed beneath the adherent bacteria, with the 
accumulation of cytoskeletal proteins, including actin, 
a-actinin, talin and ezrin. Diarrhea niay partly be 
caused by the loss of microvilli and the decreased ability 
of infected cells to absorb fluids. EPEC strains were 
previously defined as E.  coli strains of certain O:H 
serotypes associated with infantile diarrhea. Advances 
in molecular pathogenesis have demonstrated that 
pathogenicity is not restricted to the classical EPEC 
serogroups or serotypes. Some strains belonging to 
the ‘classical EPEC’ serotypes are non-pathogenic and 
some E. coli strains belonging to other serotypes but 
with LA or A-E phenotypes should be classed as EPEC. 
Classical EPEC strains are now identified by the pre- 
sence of at least two out of three virulence factors 
(EAF plasmid, b&4 or eaeA genes) rather than by 
serotyping. 
The only known virulence factor of DAEC strains 
is their diffuse pattern adherence to cultured epithelial 
cells. Two families of gene clusters encoding diffuse 
adherence have been identified in DAEC strains: 
U f A / d A A  and the AIDA (adhesin involved in diffuse 
adhesion)-encoding genes. The aja (afimbrial adhesin) 
family includes closely related gene clusters that code 
for an adhesin and an invasin involved in bacterial- 
epithelial cell interactions. Recent epidemiologic studies 
have implicated DAEC strains carrying a j ~  genes as a 
cause of acute and persistent diarrhea in 2-ti-year-old 
children in developing countries [5,6]. Several epi- 
demiologic studies have demonstrated that the AIDA- 
encoding genes are rare (0-196) in DAEC strains [5,6]. 
SLTEC strains involved in outbreaks of bloody 
diarrhea in developed countries are characterized by 
the production of toxins. The presence of an LEE locus 
also causes A-E cellular lesions similar to those caused 
by EPEC strains. SLTEC strains can be classified as 
enterohemorrhagic E. coli (EHEC) when they cause 
diarrhea or HUS. 
Question 2 
E. coli 0157:H7 was the first serotype implicated 
in outbreaks of bloody diarrhea and HUS. Over 100 
other E.  coli serotypes have now been associated with 
similar diseases. Among these, 0113:H21, 0 1  11:NM, 
0103:H2 and 0 2 6 : H l l  have been isolated from stools 
of children with HUS. 0157:H7 remains the most 
common serotype associated with H C  in the USA. 
Recent studies indicate that SLTEC strains of the 0157  
serogroup are the main cause of HUS in childhood in 
Europe [7,8]. Antibodies to 0 2 6  and 0 5 5  antigens 
have also been detected in sera of patients with HUS 
[8,9]. It seems that 0157:H7 causes major outbreaks 
more often and leads to higher rates of systemic disease 
than any other serotype [lo]. 
Cattle are thought to be the major reservoir of 
SLTEC strains. The main source of contamination is 
bovine-derived food, especially ground beef insufi- 
ciently cooked in ‘hamburgers’. However, raw milk, 
apple cider, mayonnaise and water have also been 
identified as sources of contamination. Direct person- 
to-person and cattle-to-person contacts can transmit 
the organisms, showing that SLTEC strains are highly 
infectious. Very few organisms (100 bacteria) are 
required to cause disease as is the case in shigellosis 
SLTEC strains cause a range of symptoms, some 
of which mimic non-infectious disorders such as 
[lo]. 
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appendicitis, diverticulitis, ischemic colitis, intussus- 
ception and inflammatory bowel disease. The fre- 
quency with which SLTEC strains cause non-bloody 
diarrhea is unknown, as such illness can pass unnoticed. 
The incubation period for E.  coli 0 1 5 7  infection 
is usually 3 or 4 days. SLTEC infection begins with 
watery diarrhea that becomes bloody within 1 or 2 
days. There is then abdominal pain but, unhke classic 
dysentery, it is not accompanied by fecal leukocytes 
and patients have either no or low-grade fever. The 
bloody diarrhea lasts between 4 and 10 days. There 
is a risk of developing HUS after HC, according to 
estimates based on incidence data for E. coli 0157:H7 
infections. Some patients also develop thrombotic 
thrombocytopenic purpura (TTP), a thrombotic 
microangiopathic disorder resembling HUS, associated 
with major neurologic abnormalities. This syndrome is 
not usually preceded by a diarrheal episode. 
Question 3 
Few SLTEC outbreaks have been reported in Europe 
so the incidence rate of HUS in SLTEC infections is 
unknown. E. coli 0157:H7 is identified as the causative 
agent of about 1000 cases of HUS each year in the 
USA. HUS affects people of all ages but is most often 
diagnosed in children under the age of 10. About 10% 
of E. coli 0157:H7 infections in children younger 
than 10 years old progress to overt HUS [lo]. Some 
authorities recommend that infected children should 
not return to group settings until at  least two negative 
stool cultures have been obtained, as SLTEC strains are 
highly contagious [ l l ] .  These measures may prevent 
outbreaks in day-care centers or schools. 
HUS typically develops 1 week after the onset of 
diarrhea. HUS is characterized by microangiopathic 
hemolytic anemia, thrombocytopenia and acute renal 
failure. It can be complicated by seizure, coma, hemor- 
rhagic or non-hemorrhagic strokes, colonic perforation, 
pancreatitis, glucose intolerance, hepatobiliary disorders, 
hypertension, respiratory distress syndrome and cardio- 
niyopathy. Sudden deaths account for about 15% 
of HUS-related fatalities. Some patients apparently 
recover from HUS but later develop chronic renal 
abnormalities (121. 
Other bacteria such as Citrobacter freundii and 
Enterobacter cloacae have been implicated as causative 
agents for HUS in Germany and Australia [13,14]. 
These enterobacterial isolates were found to produce 
Shiga-like toxins. Shigella dysenteriae which produces 
the Shiga toxin, also causes HUS [15]. 
Question 4 
EHEC strains (0157:H7 and non-O157:H7) produce 
the bacteriophage-encoded Shiga-like toxins (SLTs) 
that cause many of the pathologic effects of SLTEC 
infections. 
SLTs are structurally and functionally related to the 
Shiga toxin. Two different antigenic types have been 
described. The SLT type produced is not dependent on 
the serotype of the E. coli strain. SLT-I is 99% identical 
to the Shiga toxin and SLT-I1 is 55% identical to SLT- 
1. The SLT-I1 toxin is produced by 97% of EHEC 
strains, either alone or with SLT-I. The mechanism of 
action of these two toxins is similar. SLTs are hetero- 
tetramers composed of five B subunits which bind to 
the cellular receptor and a single A subunit which is 
responsible for the enzymatic activity (N-glycosidase). 
The N-glycosidase cleaves an adenosine in the 3’ 
region of the 28s rRNA component of the eukaryotic 
ribosomal complex thus inhibiting protein synthesis 
[16]. The main targets of SLT are endothelial cell beds 
in the kidney, brain and gut. The detachment of endo- 
thelial cells may expose platelets to the subendothelium 
and initiate coagulation in the capillary beds. The way 
in which the SLTs gain access from the intestinal lumen 
to the target tissues via systemic dissemination is not 
understood, but SLTs have been shown to cross intact 
intestinal epithelial cell barriers in vitro. SLTs are 
enterotoxic, effecting fluid accumulation in ligated 
rabbit ileal loops. The colonic disease that progresses to 
HUS typical of humans is not observed in animals 
but some features of the disease can be reproduced in 
the mouse system. Streptomycin-treated mice orally 
infected with SLTEC die withm 4-10 days (depending 
on the size of the inoculum). The toxicity of an E. coli 
isolate in mice is not related to the serotype but to toxin 
production. The virulence of SLTEC strains in mice 
depends on the SLT type produced by the isolate. SLT- 
I1 is much more toxic than SLT-I [17]. The amount of 
toxin produced by the isolate also affects the virulence 
of the strain. 
Question 5 
SLTEC infections are mostly detected during large 
outbreaks but they probably occur more frequently 
as sporadic cases. Identification of SLTEC strains is 
currently performed by microbiological, serologic, and 
molecular techniques but none is satisfactory. 
The microbiological approach has several problems. 
The organism is usually sought only in stools that 
are obviously bloody, so milder SLTEC infections are 
underdiagnosed. The SLTEC strain is often not isolated 
from stool cultures because it is rapidly cleared from the 
gastrointestinal tract (two-thirds of patients with HUS 
no longer have pathogenic E. coli in their stools) and 
also because detectable excretion of the strain in the 
stools is often intermittent. The SLTEC strain often 
makes up less than 1% of the aerobic fecal flora when 
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excreted by patients. Stool cultures may thus test 
negative for the organism due to the low numbers of 
SLTEC bacteria in stools. 
The E.  coli 0157:H7 serotype can be selectively 
screened in stool specimens using sorbitol-MacConkey 
(SMAC) medium. This selection is based on the fact 
that most fecal E. coli strains have a sorbitol-fermenting 
phenotype whereas E. coli 0157:H7 strains do not 
ferment sorbitol. The inclusion of potassium tellurite, 
cefixime and rhamnose in SMAC medium increases 
selection for E. coli 0157.  SMAC medium is not suit- 
able for detection of non-O157:H7 SLTEC strains 
or sorbitol-fermenting 0157:H7 strains (some have 
been described). Some non-O157:H7 SLTEC strains 
have also been identified as non-sorbitol-fermenting 
strains. 
Agglutination of a bacterial suspension by 0 
antibody-coated latex particles is the usual method 
for detection of the 0 1 5 7  antigen. This test is not 
foolproof since non-O157:H7 SLTEC strains are not 
identified. 0 1 5 7  strains can be selectively isolated from 
stools using the immunomagnetic (super paramagnetic 
beads coated with anti-0157 antibody) separation 
culture enrichment method. These results must be 
confirmed biochemically because 0 1  57 antigens from 
other bacterial pathogens can cross-react with E. coli 
0157  antiserum. 
Serologic identification is required when stool 
cultures from patients test negative during the diarrheal 
illness or when stool specimens cannot be obtained. 
Detection of antibodies against SLTs is not used, as the 
anti-SLT response in infected patients is poor. Anti- 
bodies directed against the 0 antigen have often been 
detected in the first few months after HUS. The 
magnitude of the response may be related to the 
severity of illness and is larger in patients who have 
developed HUS than in those who have not. Detection 
of antibodies against non-0157 0 antigens is less well 
documented. 
To detect SLTEC strains of both 0157:H7 and 
non-O157:H7 serotypes, hybridization techniques and 
the polymerase chain reaction are also used. These 
techniques allow rapid and specific detection of viru- 
lence factor genes specific for SLTEC strains (the SLT- 
encoding genes) [18]. The intimin-encoding eaeA gene 
can also be sought, although not all SLTEC strains 
contain the gene [19]. 
Free fecal toxin can be identified in the stools of 
some patients. The production of SLTs and the cyto- 
toxic activity in samples can be tested by determining 
the effect on the Vero cell line. However, this test is not 
easy to perform in clinical microbiological laboratories. 
Enzyme immunoassays allowing specific detection of 
SLTs in stool samples are being developed and should 
make identification of SLTEC strains of any serotype 
possible. 
Question 6 
Most E.  coli 0157:H7 isolates are susceptible to a broad 
spectrum of antibiotics such as ampicillin, trimetho- 
prim-sulfamethoxazole, tetracycline, and quinolones. 
However, the use of antibiotic treatment to eradicate 
the strain from the intestine is controversial. Toxin 
production is one of the most important factors in 
SLTEC diseases, and antibiotic treatment which kills 
the bacteria may cause an increased release of toxins in 
the intestinal lumen. Thus, such treatment may worsen 
the illness. The risk of developing HUS is the same or 
greater in patients treated with antibiotics than in those 
not treated with these agents [20,21]. No significant 
effect of trimethoprim-sulfamethoxazole treatment on 
progression of symptoms, fecal pathogen excretion or 
the incidence of HUS was found in children with 
proven E.  coli 0157:H7 enteritis [22]. Thus, further 
studies are required to investigate the safety and efficacy 
of antibiotic therapy. 
Administration of antimotility agents is not recom- 
mended for people with bloody diarrhea, because they 
may delay clearance of the pathogen from the gastro- 
intestinal tract. Also, these agents may increase the risk 
of HUS following SLTEC infection [23]. 
Intravenous rehydration with isotonic saline solut- 
ion is recommended for patients with diarrhea and 
vomiting. Seventy-five per cent of patients with HUS 
require transfixion of erythrocytes or platelets or both 
and 50% require dialysis. It is thus essential to monitor 
peripheral blood count, blood film and renal function 
of these patients. 
CONCLUSION 
E. coli is a bacterial pathogen of major importance in 
medical bacteriology. Unlike other pathogenic bacteria 
(such as Vibrio cholerae or Yersinia enterocolitica), E. coli is 
associated with different intestinal pathologies. Ideally, 
the diagnosis of enteric E. coli infection should be made 
with a combination of microbiological, biochemical, 
serological and genetic approaches. However, in 
practice, such a combination of diagnostic methods 
is rarely used. Each E.  coli pathotype is defined by 
the production of specific virulence factors. Over the 
past few years, the polymerase chain reaction (PCR) 
has become a powerful technique for detection of 
these virulence factors. In the future, P C R  assays which 
are specific, rapid and easy to perform may be 
recommended for routine clinical use to identify 
enteric E. coli of the ETEC, EIEC, EAEC, EPEC, and 
DAEC types. Immunoassays to detect SLTs in stools 
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should be developed and improved for detection of 
SLTEC strains, which are not always easy to isolate 
during infection. However, not all E. coii isolates from 
diarrheic stools can be classified into one of the six 
defined pathotypes. The development of DNA probes 
to identify these uncharacterized enteric E. coli strains 
is required for the determination of the role of these 
strains in the pathogenesis of diarrheal disease. 
Answers to the multiple-choice questions 
41:  a. False; b. False; c. True; d. False; e. True 
42:  a. False; b. False; c. False; d. True; e. False 
4 3 :  a. False; b. False; c. True; d. True; e. False 
44: a. False; b. True; c. True; d. True; e. True 
Q5: a. True; b. False; c. False; d. False; e. True 
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